EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Subtype Identification and Prognostic Prediction of Pancreatic Cancer Based on m6A / m5C / m1A ‐Related Genes

Yunyang Wang, Xueqing Hong, Dingge Cao, Mingzhen Wang, Abulaihaiti Tuergong, Hongrui Liu, Yuxuan Guo, Xia Ting, Xujun Liu iD, Xiao Huo, Wenzhe Si iD

Journal of Cellular and Molecular Medicine · 2026-06 · 30 (12)

DOI: 10.1111/jcmm.71251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 28.06.2026. Verfasst von Yunyang Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, State Key Laboratory of Vascular Homeostasis and Remodeling, Key Laboratory of Cardiovascular Molecular Biology an…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Nova Program, Beijing Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer, characterized by an unfavourable prognosis, necessitates early diagnosis and prompt therapeutic intervention. This study aimed to delineate the functional implications of m6A/m1A/m5C‐related genes in pancreatic carcinogenesis and establish a prognostic model. Utilizing data from the TCGA‐PAAD cohort (n=178) combined with GTEx normal pancreatic tissues (n=332), we identified 43 genes associated with m 6 A/m 1 A/m 5 C methylation pathways. Significant expression differences in these genes were observed between neoplastic and non‐neoplastic tissues, correlating with multiple biological pathways. Consensus clustering divided pancreatic cancer patients into two distinct molecular subtypes exhibiting pronounced survival differences. A prognostic risk‐scoring model was developed based on nine m 6 A/m 1 A/m 5 C‐related genes, demonstrating efficacy in predicting patient outcomes. We constructed a nomogram integrating clinical variables with the risk score to enhance prognostic precision. Among these genes, a comprehensive investigation was conducted using immunohistochemistry and multicolor immunofluorescence to elucidate that higher TRMT61B expression in tumour tissues is significantly associated with higher pancreatic cancer stage, and might relate to an immunosuppressive and dysfunctional tumour immune microenvironment. This study reveals the role of m 6 A/m 1 A/m 5 C associated genes, especially TRMT61B, in the epigenetic regulation of pancreatic cancer, providing evidence supporting their potential as novel prognostic biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsBiomarkers, TumorHumansPrognosisGene Expression Regulation, NeoplasticRNA MethylationGene Expression ProfilingFemaleNomogramsEpitranscriptome

Stichwörter der Autor:innen

RNA methylationTRMT61Bmolecular subtypepancreatic cancerprognostic prediction

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine, State Key Laboratory of Vascular Homeostasis and Remodeling, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing, Chin…
  • Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing, China.
  • Department of Laboratory Medicine, Peking University First Hospital, Beijing, China.
  • Center of Basic Medical Research, Peking University Third Hospital, Beijing, China.

ORCID-Profile: Xujun Liu, Wenzhe Si

Förderung

  • Beijing Nova Program
  • Beijing Natural Science Foundation
  • National Natural Science Foundation of China
  • Clinical Medicine Plus X-Young Scholars Project of Peking University
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Wang, Y., Hong, X., Cao, D., Wang, M., Tuergong, A., Liu, H., Guo, Y., Ting, X., Liu, X., Huo, X., & Si, W. (2026). Molecular Subtype Identification and Prognostic Prediction of Pancreatic Cancer Based on m6A / m5C / m1A ‐Related Genes. Journal of Cellular and Molecular Medicine, 30(12). https://doi.org/10.1111/jcmm.71251

Vancouver

Wang Y, Hong X, Cao D, Wang M, Tuergong A, Liu H, et al. Molecular Subtype Identification and Prognostic Prediction of Pancreatic Cancer Based on m6A / m5C / m1A ‐Related Genes. Journal of Cellular and Molecular Medicine. 2026;30(12). doi:10.1111/jcmm.71251

BibTeX
@article{Wang2026,
  author = {Wang, Yunyang and Hong, Xueqing and Cao, Dingge and Wang, Mingzhen and Tuergong, Abulaihaiti and Liu, Hongrui and Guo, Yuxuan and Ting, Xia and Liu, Xujun and Huo, Xiao and Si, Wenzhe},
  title = {Molecular Subtype Identification and Prognostic Prediction of Pancreatic Cancer Based on m6A / m5C / m1A ‐Related Genes},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {12},
  doi = {10.1111/jcmm.71251}
}
Kostenlos starten →